Soleus Capital Management, L.P. Astrazeneca PLC Transaction History

Soleus Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $3.38 Million - $4.05 Million	57,000 Added 50.58%	169,696 $11.2 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $20.4 Million - $24.6 Million	-365,900 Reduced 76.45%	112,696 $7.48 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $8.6 Million - $10.2 Million	159,200 Added 49.84%	478,596 $27.9 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $3.85 Million - $4.21 Million	69,250 Added 27.68%	319,396 $19.2 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $401,886 - $499,494	-8,300 Reduced 3.21%	250,146 $15 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $9.16 Million - $10.6 Million	194,162 Added 302.04%	258,446 $12.9 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $2.67 Million - $3.2 Million	55,081 Added 598.51%	64,284 $3.21 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $6.74 Million - $7.76 Million	-127,011 Reduced 93.24%	9,203 $504,000
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $5.87 Million - $7.53 Million	136,214 New	136,214 $7.2 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.